花园生物
(300401)
| 流通市值：56.86亿 | | | 总市值：57.80亿 |
| 流通股本：5.33亿 | | | 总股本：5.42亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 330,273,302.02 | 1,094,651,559.54 | 897,780,746.5 | 656,743,810.69 |
| 营业收入 | 330,273,302.02 | 1,094,651,559.54 | 897,780,746.5 | 656,743,810.69 |
| 二、营业总成本 | 260,819,419.2 | 939,881,258.26 | 751,582,374.71 | 538,591,388.19 |
| 营业成本 | 137,543,476.56 | 439,312,029.24 | 360,394,532.49 | 249,064,670.16 |
| 税金及附加 | 2,478,970.09 | 19,004,051.46 | 10,052,176.23 | 8,468,482.65 |
| 销售费用 | 64,580,483.39 | 252,361,873.14 | 212,875,026.33 | 159,958,244.58 |
| 管理费用 | 28,131,533.16 | 127,144,758.81 | 99,417,092.88 | 73,987,057.4 |
| 研发费用 | 20,557,191.99 | 90,912,026.67 | 59,925,575.6 | 42,436,499.22 |
| 财务费用 | 7,527,764.01 | 11,146,518.94 | 8,917,971.18 | 4,676,434.18 |
| 其中:利息费用 | 10,225,595.56 | 38,414,552.6 | 32,315,153.75 | 23,308,274.85 |
| 其中:利息收入 | 1,166,639.43 | 20,544,871.71 | 16,346,216.76 | 11,695,365.98 |
| 加:公允价值变动收益 | - | -63,952.08 | 264,000 | 391,800 |
| 加:投资收益 | 140,135.52 | -271,520.05 | -265,500 | - |
| 资产处置收益 | 31,380,497.72 | -39,489.53 | 937.92 | 937.92 |
| 资产减值损失(新) | 4,098.58 | -1,351,912.68 | -958,789.15 | -621,927.79 |
| 信用减值损失(新) | -1,193,617.73 | 2,385,395.15 | 449,961.75 | -500,103.33 |
| 其他收益 | 4,376,648.89 | 51,695,745.42 | 15,514,887.78 | 11,073,894.53 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 104,161,645.8 | 207,124,567.51 | 161,203,870.09 | 128,497,023.83 |
| 加:营业外收入 | 549,234.08 | 4,359,944.07 | 3,799,749.67 | 2,363,913.09 |
| 减:营业外支出 | 100,143.1 | 439,536.24 | 407,388.9 | 186,256.34 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 104,610,736.78 | 211,044,975.34 | 164,596,230.86 | 130,674,680.58 |
| 减:所得税费用 | 13,127,645.06 | 18,696,101.65 | 15,662,964.87 | 13,466,832.81 |
| 六、净利润 | 91,483,091.72 | 192,348,873.69 | 148,933,265.99 | 117,207,847.77 |
| 持续经营净利润 | - | 192,348,873.69 | 148,933,265.99 | 117,207,847.77 |
| 终止经营净利润 | 91,483,091.72 | - | - | - |
| 归属于母公司股东的净利润 | 91,483,091.72 | 192,348,873.69 | 148,933,265.99 | 117,207,847.77 |
| (一)基本每股收益 | 0.17 | 0.35 | 0.27 | 0.21 |
| (二)稀释每股收益 | 0.15 | 0.32 | 0.27 | 0.21 |
| 九、综合收益总额 | 91,483,091.72 | 192,348,873.69 | 148,933,265.99 | 117,207,847.77 |
| 归属于母公司股东的综合收益总额 | 91,483,091.72 | 192,348,873.69 | 148,933,265.99 | 117,207,847.77 |
| 公告日期 | 2024-04-16 | 2024-04-16 | 2023-10-21 | 2023-08-08 |
| 审计意见(境内) | | 标准无保留意见 | | |